Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Sergott

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Current Opinion in Ophthalmology|September 3, 2010
Recommendations for visual evaluations of patients treated with vigabatrinRobert C Sergott
International Ophthalmology Clinics|December 1, 2007
Historical perspective and future prospective for retinal nerve fiber loss in optic neuritis and multiple sclerosisRobert C Sergott
Current Pain and Headache Reports|June 7, 2012
Headaches associated with papilledemaRobert C Sergott
Current Opinion in Ophthalmology|November 3, 2005
Neuro-ophthalmology does have a futureRobert C Sergott
Current Opinion in Ophthalmology|November 3, 2005
Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritisRobert C Sergott
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 19, 2014
Retinal segmentation using multicolor laser imagingRobert C Sergott
International Ophthalmology Clinics|June 7, 2012
Vigabatrin-associated visual field lossChris Fecarotta, Robert C Sergott
Current Opinion in Ophthalmology|October 11, 2012
Gilenya safety update: cardiac and maculaAlison Huggins, Robert C Sergott
Current Opinion in Ophthalmology|September 28, 2011
Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safetyAlison Huggins, Robert C Sergott
Current Opinion in Ophthalmology|October 27, 2006
Intracranial aneurysmsMolly E Gilbert, Robert C Sergott
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Current Opinion in Ophthalmology|September 3, 2010
Recommendations for visual evaluations of patients treated with vigabatrinRobert C Sergott
International Ophthalmology Clinics|December 1, 2007
Historical perspective and future prospective for retinal nerve fiber loss in optic neuritis and multiple sclerosisRobert C Sergott
Current Pain and Headache Reports|June 7, 2012
Headaches associated with papilledemaRobert C Sergott
Current Opinion in Ophthalmology|November 3, 2005
Neuro-ophthalmology does have a futureRobert C Sergott
Current Opinion in Ophthalmology|November 3, 2005
Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritisRobert C Sergott
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 19, 2014
Retinal segmentation using multicolor laser imagingRobert C Sergott
International Ophthalmology Clinics|June 7, 2012
Vigabatrin-associated visual field lossChris Fecarotta, Robert C Sergott
Current Opinion in Ophthalmology|October 11, 2012
Gilenya safety update: cardiac and maculaAlison Huggins, Robert C Sergott
Current Opinion in Ophthalmology|September 28, 2011
Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safetyAlison Huggins, Robert C Sergott
Current Opinion in Ophthalmology|October 27, 2006
Intracranial aneurysmsMolly E Gilbert, Robert C Sergott
Pageof 10